The second, including 16 studies and 11,007 patients with CAD found that higher plasma PTX-3 levels were associated with poor prognosis independently of CAD subtype, follow-up duration, and adjustment for CRP levels [18]. The gene discussed is PTX3; the disease is coronary artery disorder.